Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 317

1.

Risperidone long-acting therapy prescribing patterns and their impact on early discontinuation of treatment in a large Medicaid population.

Boaz TL, Constantine RJ, Robst J, Becker MA, Howe AM.

J Clin Psychiatry. 2011 Aug;72(8):1079-85. doi: 10.4088/JCP.09m05348yel. Epub 2010 Oct 19.

PMID:
21034690
2.

Explicit review of risperidone long-acting injection prescribing practice.

Wheeler A, Vanderpyl J, Carswell C, Stojkovic M, Robinson E.

J Clin Pharm Ther. 2011 Dec;36(6):651-63. doi: 10.1111/j.1365-2710.2010.01219.x. Epub 2010 Nov 5.

PMID:
22023342
3.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
4.

Trends in antipsychotic prescribing practices in an urban community mental health clinic.

Monshat K, Carty B, Olver J, Castle D, Bosanac P.

Australas Psychiatry. 2010 Jun;18(3):238-41. doi: 10.3109/10398561003681327.

PMID:
20482426
5.

Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.

Ganguly R, Kotzan JA, Miller LS, Kennedy K, Martin BC.

J Clin Psychiatry. 2004 Oct;65(10):1377-88.

PMID:
15491242
6.

Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.

Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ.

Clin Ther. 2007 Jan;29(1):183-95.

PMID:
17379060
7.

[Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].

Misdrahi D, Delgado A, Bouju S, Comet D, Chiariny JF.

Encephale. 2013 May;39 Suppl 1:S8-14. doi: 10.1016/j.encep.2012.03.005. Epub 2013 Mar 28. French.

PMID:
23541914
8.

Prognostic indicators for early discontinuation of risperidone long-acting injection.

Patel MX, Young C, Samele C, Taylor DM, David AS.

Int Clin Psychopharmacol. 2004 Jul;19(4):233-9.

PMID:
15201571
9.

A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.

Weiden PJ, Schooler NR, Weedon JC, Elmouchtari A, Sunakawa A, Goldfinger SM.

J Clin Psychiatry. 2009 Oct;70(10):1397-406. doi: 10.4088/JCP.09m05284yel.

PMID:
19906343
10.

Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.

Citrome L, Jaffe A, Levine J.

Schizophr Res. 2010 Jun;119(1-3):153-9. doi: 10.1016/j.schres.2010.02.1066. Epub 2010 Mar 26.

PMID:
20347267
11.

[Evaluation of prescription practices of long acting injectable risperidone in French hospitals].

Bret P, Heil M, Queuille E, Bret MC; RĂ©seau Pic.

Encephale. 2011 May;37 Suppl 1:S58-65. doi: 10.1016/j.encep.2010.04.001. Epub 2010 May 20. French.

PMID:
21600335
12.

[Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].

Raignoux C, Dusouchet T, Bret P, Queuille E, Biscay ML, Caron J, Bret MC.

Encephale. 2007 Dec;33(6):973-81. doi: 10.1016/j.encep.2006.07.003. Epub 2007 Sep 4. French.

PMID:
18789790
13.

Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic.

Fleischhacker WW, Eerdekens M, Karcher K, Remington G, Llorca PM, Chrzanowski W, Martin S, Gefvert O.

J Clin Psychiatry. 2003 Oct;64(10):1250-7.

PMID:
14658976
14.
15.

Long-acting risperidone in young adults with early schizophrenia or schizoaffective illness.

Lasser RA, Bossie CA, Zhu Y, Locklear JC, Kane JM.

Ann Clin Psychiatry. 2007 Apr-Jun;19(2):65-71.

PMID:
17612845
16.
17.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

18.

Prevalence of concomitant oral antipsychotic drug use among patients treated with long-acting, intramuscular, antipsychotic medications.

Aggarwal NK, Sernyak MJ, Rosenheck RA.

J Clin Psychopharmacol. 2012 Jun;32(3):323-8. doi: 10.1097/JCP.0b013e31825244f6.

PMID:
22544006
19.
20.

Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.

Clark RE, Xie H, Brunette MF.

J Clin Psychiatry. 2004 Feb;65(2):151-5.

PMID:
15003066

Supplemental Content

Support Center